NJ State Employees Deferred Compensation Plan’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
NJ State Employees Deferred Compensation Plan's OMED Position: Q2 2019 in Review
NJ State Employees Deferred Compensation Plan sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 38,000 shares — an estimated $40K sold.
NJ State Employees Deferred Compensation Plan first reported a position in OMED in Q4 2015 and held it in 14 quarters. The position peaked at $1.58M in Q4 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.
- NJ State Employees Deferred Compensation Plan reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
- NJ State Employees Deferred Compensation Plan sold 38,000 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $40K.
- NJ State Employees Deferred Compensation Plan first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
- NJ State Employees Deferred Compensation Plan's OncoMed Pharmaceuticals, Inc. position peaked at $1.58M in Q4 2015.
- 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2019, filed 24 Jul 2019.